Inventor · disambiguated record
Karine Fabienne Malagu
Also filed as: MALAGU KARINE · MALAGU KARINE FABIENNE
31 granted patents·5 pending applications·112 citations·filing 2007–2022
96Inventor score
Top patents by PatentIndex Score
36 records- 0195US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0294US8101602B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsMENEAR KEITH·Filed 2011·Granted Jan 24, 2012·19 cites·9 claims
- 0391US9079909B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher SyndromeUSHER III INITIATIVE·Filed 2013·Granted Jul 14, 2015·8 cites·14 claims
- 0491US8765762B2Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE·Filed 2013·Granted Jul 1, 2014·11 cites·18 claims
- 0590US9549910B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Jan 24, 2017·3 cites·2 claims
- 0690US9260381B2Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Feb 16, 2016·4 cites·2 claims
- 0790US9227976B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2013·Granted Jan 5, 2016·6 cites·38 claims
- 0890US9102670B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2013·Granted Aug 11, 2015·5 cites·6 claims
- 0988US7902189B2CompoundsASTRAZENECA AB·Filed 2007·Granted Mar 8, 2011·6 cites·10 claims
- 1087US9783545B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2016·Granted Oct 10, 2017·3 cites·16 claims
- 1187US9371332B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndromeUSHER III INITIATIVE INC·Filed 2015·Granted Jun 21, 2016·4 cites·2 claims
- 1286US8435985B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsMENEAR KEITH·Filed 2011·Granted May 7, 2013·3 cites·8 claims
- 1385US11806346B2HTT modulators for treating Huntington's diseaseCHDI FOUNDATION INC·Filed 2021·Granted Nov 7, 2023·1 cites·37 claims
- 1485US10307422B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2018·Granted Jun 4, 2019·1 cites·2 claims
- 1582US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 1682US9925187B2Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndromeUSHER III INITIATIVE INC·Filed 2016·Granted Mar 27, 2018·1 cites·3 claims
- 1779US11492347B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Nov 8, 2022·1 cites·12 claims
- 1879US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 1979US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 2072US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 2171US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 2271US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 2371US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 2470US11279683B2Thiophene derivatives as antiviral agentsENYO PHARMA·Filed 2017·Granted Mar 22, 2022·1 cites·9 claims
- 2569US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 2665US10034884B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2017·Granted Jul 31, 2018·0 cites·4 claims
- 2763US11807618B2Thiophene derivatives as antiviral agentsENYO PHARMA·Filed 2022·Granted Nov 7, 2023·0 cites·7 claims
- 2860US11603368B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Mar 14, 2023·0 cites·2 claims
- 2959US11840527B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Dec 12, 2023·0 cites·8 claims
- 3058US11767316B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 3158US9717736B2Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitorsKUDOS PHARM LTD·Filed 2015·Granted Aug 1, 2017·0 cites·4 claims
- 3257US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 3356US12281116B2HTT modulators for treating Huntington's diseaseCHDI FOUNDATION INC·Filed 2022·Granted Apr 22, 2025·0 cites·19 claims
- 3455US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 3554US2018037587A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2017·Application pending·0 cites
- 3645US2008194546A1Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR InhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karine Fabienne Malagu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →